J-P Salles, Toulouse
Your health journey is our passion, and these stories inspire us to continue providing exceptional care.
Cardiovascular, mortality, and kidney outcomes with GLP1 receptor agonists in patients with type 2 diabetes: A systematic review and metaanalysis of randomised trials
Yes, athletes, particularly those in bodybuilding and high-intensity sports, use BPC-157 to support faster recovery, reduce injury downtime, and improve overall performance
Will the Olympic face go away
Even though it is curable at an early stage, novel drug identification, clinical success, and drug resistance is another major challenge